Patents by Inventor Ta Deng

Ta Deng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CRYSTAL FORM AND SALT OF PHENOTHIAZINE COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF
    Publication number: 20250145605
    Abstract: Provided are a crystal form and salt of a phenothiazine compound, a preparation method therefor and a use thereof. A hydrochloride of the phenothiazine compound and a crystal thereof can be used as ferroptosis inhibitors, and the hydrochloride and the crystal thereof have relatively good solubility, stability, oral absorption bioavailability, and druggability.
    Type: Application
    Filed: January 19, 2023
    Publication date: May 8, 2025
    Applicant: CHENGDU HENGHAO INNOVATIVE SCIENCE AND TECHNOLOGY CO., LTD.
    Inventors: Zhou YU, Peng HE, Guangxin DONG, Yi LI, Rui ZHANG, Ta DENG, Qijun YE, Pei HUANG, Shan LI, Bogang LI
  • Benzimidazole Or Azabenzimidazole Compound, Preparation Method Therefor And Use Thereof
    Publication number: 20250136584
    Abstract: The invention discloses a benzimidazole or azabenzimidazole compound, a preparation method therefor and use thereof. The benzimidazole or azabenzimidazole compound has a structure shown in formula (I). Use of the compound and a pharmaceutically acceptable salt, a stereoisomer, a solvate or a hydrate thereof in preparing a GLP-1 receptor agonist and use thereof in preparation of a medicament for treating and/or preventing metabolic diseases.
    Type: Application
    Filed: May 18, 2023
    Publication date: May 1, 2025
    Applicant: Chengdu Di'Ao Jiuhong Pharmaceutical Factory
    Inventors: Peng He, Zhou Yu, Guangxin Dong, Ta Deng, Rui Zhang, Qijun Ye, Shaofeng Zhang, Yong Zhang, Juan Zhang, Pei Huang, Shan Li, Bogang Li
  • Crystal Forms, Preparation Method And Application Of Aryl Phosphine Oxide Compound
    Publication number: 20240376138
    Abstract: The present invention relates to a polymorph of an aryl phosphorus oxide compound and a dihydrate crystal form thereof, and a preparation method therefor and a use thereof. The crystalline aryl phosphorus oxide compound and dihydrate crystal form thereof can be used as EGFR and/or ALK inhibitors, in addition, the dihydrate crystal has relatively good stability and is not hygroscopic.
    Type: Application
    Filed: August 23, 2022
    Publication date: November 14, 2024
    Applicant: Chengdu Di'Ao Jiuhong Pharmaceutical Factory
    Inventors: Peng He, Bongang Li, Zhou Yu, Guangxin Dong, Haiyan Li, Ta Deng, Rui Zhang, Pei Huang
  • ARYL PHOSPHOROUS OXIDE COMPOUNDS AND USE THEREOF
    Publication number: 20230322822
    Abstract: The present invention provides aryl phosphorous oxide compounds with kinase inhibitory activity. The compounds are capable of effectively inhibiting activity of various types of EGFR drug-resistant mutants (such as EGFRdel19, EGFRdel19/T790M, EGFRdel19/C797S, EGFRT790M/L858R, EGFRL858/C797S, EGFRdel19/T790M/C797S, and EGFRL858R/T790M/C797S, and also have significant inhibitory effect on ALK fusion genes and mutants (such as L1196M), and are capable of being used for the treatment, combined treatment or prevention of various types of cancers.
    Type: Application
    Filed: July 2, 2021
    Publication date: October 12, 2023
    Applicant: Chengdu Di'ao Jiuhong Pharmaceutical Factory
    Inventors: Peng He, Guangxin Dong, Hai Zhao, Xuechao Wang, Shuang Chen, Pei Huang, Ta Deng, Ru Zhang, Haiyan LI
  • Borate compound, and synthesis method therefor and uses thereof
    Patent number: 11414437
    Abstract: A borate compound serving as a proteasome inhibitor, a preparation method for the borate compound and uses thereof.
    Type: Grant
    Filed: July 27, 2018
    Date of Patent: August 16, 2022
    Assignee: CHENGDU ORIGIN BIOTECHNOLOGY LIMITED COMPANY
    Inventors: Peng He, Xuechao Wang, Ta Deng, Hai Zhao, Shuang Chen, Haiyan Li, Guangxin Dong
  • BORATE COMPOUND, AND SYNTHESIS METHOD THEREFOR AND USES THEREOF
    Publication number: 20200165272
    Abstract: A borate compound serving as a proteasome inhibitor, a preparation method for the borate compound and uses thereof.
    Type: Application
    Filed: July 27, 2018
    Publication date: May 28, 2020
    Inventors: Peng HE, Xuechao WANG, Ta DENG, Hai ZHAO, Shuang CHEN, Haiyan LI, Guangxin DONG
  • Compositions and methods for the therapy and diagnosis of breast cancer
    Patent number: 7241876
    Abstract: Compositions and methods for the therapy and diagnosis of cancer, particularly breast cancer, are disclosed. Illustrative compositions comprise one or more breast tumor polypeptides, immunogenic portions thereof, polynucleotides that encode such polypeptides, antigen presenting cell that expresses such polypeptides, and T cells that are specific for cells expressing such polypeptides. The disclosed compositions are useful, for example, in the diagnosis, prevention and/or treatment of diseases, particularly breast cancer.
    Type: Grant
    Filed: August 7, 2001
    Date of Patent: July 10, 2007
    Assignee: Corixa Corporation
    Inventors: Tony N. Frudakis, Steven G. Reed, John M. Smith, Lynda E. Misher, Davin C. Dillon, Marc W. Retter, Aijun Wang, Yasir A. W. Skeiky, Susan L. Harlocker, Craig H. Day, Samuel X. Li, Ta Deng
  • Compositions and methods for the therapy and diagnosis of prostate cancer
    Publication number: 20060269532
    Abstract: Compositions and methods for the therapy and diagnosis of cancer, particularly prostate cancer, are disclosed. Illustrative compositions comprise one or more prostate-specific polypeptides, immunogenic portions thereof, polynucleotides that encode such polypeptides, antigen presenting cell that expresses such polypeptides, and T cells that are specific for cells expressing such polypeptides. The disclosed compositions are useful, for example, in the diagnosis, prevention and/or treatment of diseases, particularly prostate cancer.
    Type: Application
    Filed: February 1, 2006
    Publication date: November 30, 2006
    Applicant: Corixa Corporation
    Inventors: Jiangchun Xu, Davin Dillon, Jennifer Mitcham, Susan Harlocker, Yuqiu Jiang, Robert Henderson, Michael Kalos, Gary Fanger, Marc Retter, John Stolk, Craig Day, Thomas Vedvick, Darrick Carter, Samuel Li, Aijun Wang, Yasir Skeiky, William Hepler, John Hural, Patricia McNeill, Raymond Houghton, Carlota Vinals y de Bassols, Teresa Foy, Yoshihiro Watanabe, Madeleine Meagher, Ta Deng
  • Prostate-specific polynucleotide compositions
    Patent number: 7033827
    Abstract: Compositions and methods for the therapy and diagnosis of cancer, particularly prostate cancer, are disclosed. Illustrative compositions comprise one or more prostate-specific polypeptides, immunogenic portions thereof, polynucleotides that encode such polypeptides, antigen presenting cell that expresses such polypeptides, and T cells that are specific for cells expressing such polypeptides. The disclosed compositions are useful, for example, in the diagnosis, prevention and/or treatment of diseases, particularly prostate cancer.
    Type: Grant
    Filed: May 9, 2002
    Date of Patent: April 25, 2006
    Assignee: Corixa Corporation
    Inventors: Jiangchun Xu, Davin C. Dillon, Jennifer L. Mitcham, Susan L. Harlocker, Yuqiu Jiang, Robert A. Henderson, Michael D. Kalos, Gary R. Fanger, Marc W. Retter, John A. Stolk, Craig H. Day, Thomas S. Vedvick, Darrick Carter, Samuel X. Li, Aijun Wang, Yasir A. W. Skeiky, William T. Hepler, John Hural, Patricia D. McNeill, Raymond L. Houghton, Carlota Vinals y de Bassols, Teresa M. Foy, Yoshihiro Watanabe, Madeleine Joy Meagher, Ta Deng
  • Compositions and methods for the therapy and diagnosis of breast cancer
    Publication number: 20040073016
    Abstract: Compositions and methods for the therapy and diagnosis of cancer, particularly breast cancer, are disclosed. Illustrative compositions comprise one or more breast tumor polypeptides, immunogenic portions thereof, polynucleotides that encode such polypeptides, antigen presenting cell that expresses such polypeptides, and T cells that are specific for cells expressing such polypeptides. The disclosed compositions are useful, for example, in the diagnosis, prevention and/or treatment of diseases, particularly breast cancer.
    Type: Application
    Filed: February 20, 2002
    Publication date: April 15, 2004
    Applicant: Corixa Corporation
    Inventors: Tony N. Frudakis, Steven G. Reed, John M. Smith, Lynda E. Misher, Davin C. Dillon, Marc W. Retter, Aijun Wang, Yasir A.W. Skeiky, Susan L. Harlocker, Craig H. Day, Samuel X. Li, Ta Deng
  • Compositions and methods for the therapy and diagnosis of prostate cancer
    Publication number: 20030157089
    Abstract: Compositions and methods for the therapy and diagnosis of cancer, particularly prostate cancer, are disclosed. Illustrative compositions comprise one or more prostate-specific polypeptides, immunogenic portions thereof, polynucleotides that encode such polypeptides, antigen presenting cell that expresses such polypeptides, and T cells that are specific for cells expressing such polypeptides. The disclosed compositions are useful, for example, in the diagnosis, prevention and/or treatment of diseases, particularly prostate cancer.
    Type: Application
    Filed: May 9, 2002
    Publication date: August 21, 2003
    Applicant: Corixa Corporation
    Inventors: Jiangchun Xu, Davin C. Dillon, Jennifer L. Mitcham, Susan L. Harlocker, Yuqiu Jiang, Robert A. Henderson, Michael D. Kalos, Gary R. Fanger, Marc W. Retter, John A. Stolk, Craig H. Day, Thomas S. Vedvick, Darrick Carter, Samuel X. Li, Aijun Wang, Yasir A.W. Skeiky, William T. Hepler, John Hural, Patricia D. McNeill, Raymond L. Houghton, Carlota Vinals y de Bassols, Teresa M. Foy, Yoshihiro Watanabe, Madeleine Joy Meagher, Ta Deng
  • Compositions and methods for the therapy and diagnosis of breast cancer
    Publication number: 20020165371
    Abstract: Compositions and methods for the therapy and diagnosis of cancer, particularly breast cancer, are disclosed. Illustrative compositions comprise one or more breast tumor polypeptides, immunogenic portions thereof, polynucleotides that encode such polypeptides, antigen presenting cell that expresses such polypeptides, and T cells that are specific for cells expressing such polypeptides. The disclosed compositions are useful, for example, in the diagnosis, prevention and/or treatment of diseases, particularly breast cancer.
    Type: Application
    Filed: August 7, 2001
    Publication date: November 7, 2002
    Inventors: Tony N. Frudakis, Steven G. Reed, John M. Smith, Lynda E. Misher, Davin C. Dillon, Marc W. Retter, Aijun Wang, Yasir A.W. Skeiky, Susan L. Harlocker, Craig H. Day, Samuel X. Li, Ta Deng